Private equity group and biotech investor acquire Australian CDMO, rebrand it as AcuraBio 01-Sep-2022 By Jane Byrne Luina Bio, an Australian biopharmaceutical CDMO, has been acquired by a biotech investor and a private equity group, namely Dr Glenn Haifer and Ampersand Capital Partners.